These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3129276)

  • 1. [Insulin therapy of obese diabetic patients? Consequences for the evaluation of insulin secretion and metabolic behavior].
    Verlohren HJ; Danneberg G; Brunner E; Pohl A; Bierwolf B
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):311-25. PubMed ID: 3129276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.
    Welle S; Nair KS; Lockwood D
    J Clin Endocrinol Metab; 1988 Mar; 66(3):593-7. PubMed ID: 3127418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of sodium salicylate on insulin secretion and blood glucose behavior in metabolically healthy and type II diabetic patients].
    Wünsch C; Lohmann D; Verlohren HJ
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):317-24. PubMed ID: 3912157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin dependent) diabetes.
    Hother-Nielsen O; Schmitz O; Andersen PH; Pedersen O; Beck-Nielsen H
    Diabetes Res; 1988 Jun; 8(2):63-70. PubMed ID: 3147830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of glyburide and insulin treatment to decrease leucine flux in obese type II diabetic patients.
    Welle S; Nair KS
    Int J Obes; 1990 Aug; 14(8):701-10. PubMed ID: 2121656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics.
    Hayes JR; Callaghan S; Grant AP
    Diabete Metab; 1979 Sep; 5(3):207-11. PubMed ID: 115730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control.
    Song MK; Rosenthal MJ; Song AM; Yang H; Ao Y; Yamaguchi DT
    Metabolism; 2005 Nov; 54(11):1480-9. PubMed ID: 16253637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of diet therapy in patients with non-insulin-dependent diabetes mellitus.
    Wolffenbuttel BH; Weber RF; Van Koetsveld PM; Verschoor L
    Int J Obes; 1989; 13(2):173-82. PubMed ID: 2744929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
    Laurenti O; Bravi MC; Faldetta MC; De Mattia G
    Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion.
    Mauerhoff T; Ketelslegers JM; Lambert AE
    Diabete Metab; 1986 Feb; 12(1):34-8. PubMed ID: 3084315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide.
    Beck-Nielsen H; Pedersen O; Lindskov HO
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):451-62. PubMed ID: 106617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of glibenclamide therapy on carbohydrate and lipid metabolism and insulin secretion in patients with glucose tolerance disorders : a 5-year study].
    Ratzmann KP; Witt S; Schulz B; Jahr D; Heinke P
    Z Gesamte Inn Med; 1981 Dec; 36(23):913-7. PubMed ID: 6805141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucose tolerance and insulin secretion in relation to age in type-II diabetes--a contribution to the pathogenesis of type-II diabetes mellitus].
    Verlohren HJ; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(2):77-8. PubMed ID: 6383778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretion, carbohydrate tolerance, fat metabolism and body weight in maturity onset diabetics requiring various methods of therapy.
    Verlohren HJ; Ellorhaoui M; Lohmann D; Pohl A
    Endokrinologie; 1978 Apr; 71(2):192-203. PubMed ID: 97078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.